IIM
PHAT icon

INTECH Investment Management’s Phathom Pharmaceuticals PHAT Stock Holding History

INTECH Investment Management’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124K Buy
11,388
+40
+0.4% +$456 ﹤0.01% 1907
2026
Q1 		$126K Sell
11,348
-7,703
-40% -$97.3K ﹤0.01% 1849
2025
Q4 		$316K Sell
19,051
-2,490
-12% -$35.6K ﹤0.01% 1738
2025
Q3 		$254K Sell
21,541
-6,651
-24% -$68.6K ﹤0.01% 1924
2025
Q2 		$270K Buy
28,192
+6,708
+31% +$37.1K ﹤0.01% 1928
2025
Q1 		$135K Buy
21,484
+4,060
+23% +$24.6K ﹤0.01% 2230
2024
Q4 		$141K Buy
17,424
+5,981
+52% +$74.1K ﹤0.01% 2133
2024
Q3 		$207K Buy
+11,443
New +$160K ﹤0.01% 1701

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

INTECH Investment Management's PHAT Position: Q2 2026 in Review

INTECH Investment Management increased its Phathom Pharmaceuticals (PHAT) stake by 0.35% in Q2 2026, buying an estimated $456 and bringing the position to 11,388 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #1907.

INTECH Investment Management first reported a position in PHAT in Q3 2024 and has held it in 8 quarters since. The position peaked at $316K in Q4 2025. 162 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • INTECH Investment Management held 11,388 shares of Phathom Pharmaceuticals worth $124K as of Q2 2026.
  • INTECH Investment Management bought 40 Phathom Pharmaceuticals shares in Q2 2026, an estimated $456.
  • Phathom Pharmaceuticals made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1907 holding.
  • INTECH Investment Management first reported a position in Phathom Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Phathom Pharmaceuticals position peaked at $316K in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.